<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:NKTR (USA) Also Trade In: Germany Mexico UK

Nektar Therapeutics Inc $ 17.27 -0.5 (-2.81%)

On watch
Volume:
4,903,607
Avg Vol (1m):
3,977,558
Market Cap $:
3.03 Bil
Enterprise Value $:
1.86 Bil
P/E (TTM):
0.00
P/B:
1.94
Warning! GuruFocus has detected 4 Severe warning signs with NKTR. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

5/10
Current Vs Industry Vs History
Cash-To-Debt 4.38
Equity-to-Asset 0.74
Debt-to-Equity 0.22
Debt-to-EBITDA -0.94
N/A
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.55
DISTRESS
GREY
SAFE
Beneish M-Score 4.32
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -85.13 %
WACC 19.92 %

Profitability

3/10
Current Vs Industry Vs History
Operating Margin % -361.46
N/A
Net Margin % -354.9
N/A
ROE % -24.7
ROA % -19.25
ROC (Joel Greenblatt) % -423.08
3-Year Revenue Growth Rate 56.1

Ratios

Current Vs Industry Vs History
PB Ratio 1.94
PS Ratio 25.55
EV-to-EBIT -4.86
N/A
EV-to-EBITDA -5.02
N/A
EV-to-Revenue 15.6
Current Ratio 14.09
Quick Ratio 13.97
Days Inventory 197.84
Days Sales Outstanding 114.28
Days Payable 150.26

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.2